Disruptability [+]

Species Disruptability Reference Submitter
P. berghei ANKA
Possible
PlasmoGEM (Barseq) Imported from PlasmoGEM

Mutant phenotypes [+]

None reported yet. Please press the '+' button above to add one.

Imaging data (from Malaria Metabolic Pathways)

Mislocalization of Rab5 proteins by fosmidomycin treatment. (A and B) Confocal immunofluorescence with either anti-PfRab5a (A) or anti-PfRab5c (B) antibody in untreated parasites (control) compared to fosmidomycin-treated (FSM) and fosmidomycin- and geranylgeraniol-treated (FSM GG-ol) parasites. FITC, fluorescein isothiocyanate. protein prenylation is typically required for the localization and function of small GTPases, such as Rab5. Pf-Rab5a and Pf-Rab5c were dispersed in punctae throughout malaria parasite cells . Upon fosmidomycin treatment, a dramatic mislocalization of Rab5a occurred in the majority of treated cells, such that Rab5a was no longer present within the parasite cell but instead was found at the membrane of the host erythrocyte. Similarly, fosmidomycin treatment mislocalized Rab5c, which became diffusely localized throughout both the parasite cell and the host erythrocyte cytoplasm.Howe R, Kelly M, Jimah J, Hodge D, Odom AR. Isoprenoid biosynthesis inhibition disrupts Rab5 localization and food vacuolar integrity in Plasmodium falciparum. Eukaryot Cell. 2013 Feb;12(2):215-23. PMID:

See original on MMP

More information

PlasmoDB PBANKA_0206500
GeneDB PBANKA_0206500
Malaria Metabolic Pathways Localisation images
Pathways mapped to
Previous ID(s) PB000519.01.0, PBANKA_020650
Orthologs PCHAS_0204900 , PF3D7_0106800 , PKNH_0206700 , PVP01_0208000 , PVX_081430 , PY17X_0207900
Google Scholar Search for all mentions of this gene